CARE Ratings Ltd
CARE Ratings Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
CARE Ratings aims to consistently outpace industry growth, targeting high double-digit revenue growth in FY '26 and FY '27. The company expects high double-digit revenue growth to continue in FY '26 and FY '27.
From CARE Ratings Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- CARE Ratings aims to consistently outpace industry growth, targeting high double-digit revenue growth in FY '26 and FY '27.
- Growth drivers include expansion across multiple segments such as corporate infra, BFSI, and MCG, with a verticalized business development approach.
- Non-ratings businesses, including ESG services, analytics, and advisory segments, are scaling up and expected to contribute significantly.
- Focus on increasing market share in bond and securitization markets continues, supported by robust client onboarding, especially in 'A' and above categories.
- Digital initiatives like CRM deployment and AI-driven analytics platforms (EdgeAvira.AI) are expected to enhance sales efficiency and product adoption.
2 more points from CARE Ratings Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- CARE Ratings is focused on strategic investments to scale up non-Rating businesses faster, exploring inorganic opportunities that align with their organically grown segments (Page 14).
- Investments continue in people and technology, including AI and LLM models, to improve product quality, operational efficiency, and compliance (Pages 6, 7, 13).
- They are committed to capital allocation balancing talent retention and operating leverage benefits, keeping employee costs controlled while investing in the right skill sets (Page 13).
2 more points from CARE Ratings Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from CARE Ratings Ltd's call on order book
Pro opens every point from 15K+ earnings calls
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings's management said in earlier quarters
- Q1 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- Dam Capital Advi (Q4 FY25)
Total Income for Q4FY25: INR 37 Cr, down from INR 85 Cr in Q4FY24 (56.5% decrease YoY). Key concall takeaways from Dam Capital Advisors Ltd's Q4 FY25 earnings…
- Computer Age Management Services Ltd (Q4 FY25)
KRA business accounts have grown from 1.8 crore to over 1.9 crore PANs, with significant penetration potential in demat and broking accounts. Key concall…
- N S D L (Q4 FY25)
The contribution of subsidiaries to consolidated profits increased from 5% to 10%, indicating rising diversification benefits. Key concall takeaways from…
- Share India Sec. (Q4 FY25)
Retail client base has grown by 30% year-on-year, with institutional clients and MTF book also showing significant growth (e.g., MTF book up 330%). Key concall…
Arthneeti Pro · Annual
CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were CARE Ratings Ltd Q4 FY25 results?
CARE Ratings aims to consistently outpace industry growth, targeting high double-digit revenue growth in FY '26 and FY '27. The company expects high double-digit revenue growth to continue in FY '26 and FY '27.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 30.7 with a market cap of ₹5,263 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
CARE Ratings is focused on strategic investments to scale up non-Rating businesses faster, exploring inorganic opportunities that align with their organically grown segments (Page 14).
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.